Ekso Bionics (EKSO) Projected to Post Earnings on Monday

Ekso Bionics (NASDAQ:EKSO) is anticipated to post its quarterly earnings results before the market opens on Monday, March 3rd. Analysts expect Ekso Bionics to post earnings of ($0.07) per share and revenue of $5.05 million for the quarter.

Ekso Bionics Stock Performance

EKSO stock opened at $0.55 on Monday. The company has a market cap of $12.01 million, a P/E ratio of -0.84 and a beta of 1.46. Ekso Bionics has a 1 year low of $0.47 and a 1 year high of $2.16. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.81 and a quick ratio of 2.14. The stock’s fifty day moving average price is $0.63 and its 200-day moving average price is $0.84.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Lake Street Capital dropped their price target on Ekso Bionics from $2.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th. HC Wainwright restated a “buy” rating and issued a $9.00 price target on shares of Ekso Bionics in a research note on Tuesday, January 14th. Finally, StockNews.com assumed coverage on Ekso Bionics in a research note on Sunday. They issued a “hold” rating on the stock.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.